Tango Therapeutics TNGX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Tango Therapeutics’s reported figures.
Based on the most recent quarter.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's current ratio?
- Tango Therapeutics (TNGX) reported current ratio of 27.4× in Q1 2026.
- How has Tango Therapeutics's current ratio changed year-over-year?
- Tango Therapeutics's current ratio increased by 337.2% year-over-year, from 6.3× to 27.4×.
- What is the long-term trend for Tango Therapeutics's current ratio?
- Over 5 years (2020 to 2025), Tango Therapeutics's current ratio has grown at a 28.1% compound annual growth rate (CAGR), from 4.7× to 16.3×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.